Scott Canute
Founder at Magis Consulting LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Lawrence Kenyon | M | 58 | 9 years | |
Randy Thurman | M | 74 | 6 years | |
Andrew Dickinson | M | 54 | 4 years | |
Kurt Hilzinger | M | 63 |
University of Michigan
| 14 years |
Christina Carlson | F | - | 4 years | |
Faisal Ghiath Munir Sukhtian | M | 39 | 7 years | |
Carolyn Beaty Scimemi | F | - | 8 years | |
Cynthia Smith | F | 55 | 6 years | |
Brett Pletcher | M | 56 | 4 years | |
Yazan Haddadin | M | 48 | 7 years | |
Steven Gilman | M | 71 | 6 years | |
Adrian Adams | M | 73 | 6 years | |
Michael Rogers | M | 64 | 6 years | |
Jon Fyrwald | M | 63 | 19 years | |
Scott A. Young | M | - | 8 years | |
Robert Bartlett | M | - |
University of Michigan
| 44 years |
Dennis G. Severance | M | 80 |
University of Michigan
| 46 years |
Edgardo Hernandez | M | - | 19 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael Clayman | M | 72 | 14 years | |
David M. Goldenberg | M | 85 | 36 years | |
Henri A. Termeer | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 years |
Karen L. Tubridy | M | 61 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 2 years |
Harout Semerjian | M | 52 | - | |
Michael Pehl | M | 60 | 2 years | |
Donald Griffith | M | 75 | 7 years | |
Nicole Hadas | F | 51 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 12 years |
George H. Vincent | M | - |
University of Michigan
| 7 years |
Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
John Butler | M | 59 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 years |
Muneer Satter | M | 63 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 7 years |
Mitch A. Mondry | M | - |
University of Michigan
| 8 years |
Gregory D. Phelps | M | 75 | 8 years | |
C. Merrifield | F | 73 | 7 years | |
Usama Mohammad Fayyad | M | 60 |
University of Michigan
| 11 years |
Sahijdak Walter | M | - |
University of Michigan
| 32 years |
Michael R. Garone | M | 66 | 3 years | |
Michael Wyzga | M | 69 | 4 years | |
Robin Hoke | F | - | 2 years | |
Webster Dunbar | M | 62 | 5 years | |
Neil Bodick | M | 77 | 13 years | |
Theresa McNeely | F | 60 | 2 years | |
Joe Thomas | M | - | 2 years | |
Jodie Morrison | F | 48 | 2 years | |
Christina Willwerth | F | 53 | 12 years | |
Lisa Davidson | F | 58 | 6 years | |
William R. Gillespie | M | - |
University of Michigan
| 4 years |
David Arkowitz | M | 62 | 3 years | |
Usama Malik | M | 49 | 3 years | |
Katherine A. Lauer | F | - |
University of Michigan
| 7 years |
Daniel Hamburger | M | 60 |
University of Michigan
| 5 years |
Beverly J. Seay | F | - |
University of Michigan
| 6 years |
Izzet Garih | M | 63 |
University of Michigan
| 5 years |
Mark de Rosch | M | 61 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 6 years |
Charles Baum | M | 65 | 1 years | |
Dmitry Kobyzev | M | 38 | 2 years | |
Kevyn Duane Orr | M | 66 |
University of Michigan
| 8 years |
Pedro Granadillo | M | 77 | 34 years | |
Jöerg Windisch | M | 53 | 1 years | |
John Yee | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
Fred Driscoll | M | 74 | 5 years | |
Matthew P. Kowalsky | M | 52 | 3 years | |
Robert Barnett | M | - |
University of Michigan
| 7 years |
Paul F. DePond | M | 69 |
University of Michigan
| 5 years |
Jared M. Freedberg | M | 55 | 2 years | |
KULDEEP NEOTE | M | - | 17 years | |
Mallory Morales | F | 40 | 2 years | |
Duane Nash | M | 53 | 5 years | |
Samuel D. Colella | M | 84 | 13 years | |
Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
Jeffrey Henderson | M | 59 | 7 years | |
Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
Tony Kingsley | M | 60 | 4 years | |
Barbara Duncan | F | 59 | 1 years | |
Arthur Chadwick | M | 67 |
University of Michigan
| 6 years |
Anmar Karim Sarafa | M | - |
University of Michigan
| 4 years |
Scott D. Kelley | M | 65 | 5 years | |
Alan Milinazzo | M | 64 | 10 years | |
Haithem Karim Sarafa | M | - |
University of Michigan
| 5 years |
Ronald Renaud | M | 55 | 4 years | |
Elliot Noma | M | - |
University of Michigan
| 4 years |
Mary L. Campbell | F | - |
University of Michigan
| 2 years |
Patrick Mahaffy | M | 61 | 12 years | |
Anupam Dalal | M | 52 | 8 years | |
Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Guru Kothandaraman | M | - |
University of Michigan
| 5 years |
Heath Lukatch | M | 56 | 9 years | |
Roy Liu | M | 63 |
University of Michigan
| 10 years |
Timothy Haines | M | 67 | 5 years | |
Andrew Schwab | M | 53 | 6 years | |
Michael Heffernan | M | 59 | 4 years | |
Prokopios Tsirigakis | M | 69 |
University of Michigan
| 5 years |
John Sloss | M | - |
University of Michigan
| 7 years |
Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Michael J. Barton | M | - |
University of Michigan
| 6 years |
Jim DePorre | M | - |
University of Michigan
| 8 years |
Rolf K. Hoffmann | M | 64 | 17 years | |
Per A. Ramfjord | M | - |
University of Michigan
| 8 years |
Mark Enyedy | M | 60 | 3 years | |
Hung Shih | M | 68 |
University of Michigan
| 5 years |
Gil Syswerda | M | - |
University of Michigan
| 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Scott Canute
- Personal Network